LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 162 filers reported holding LEGEND BIOTECH CORP in Q3 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,843,959 | -13.5% | 72,072 | -11.1% | 1.15% | -4.3% |
| Q2 2023 | $5,600,853 | +6.1% | 81,113 | -25.8% | 1.20% | +3.0% |
| Q1 2023 | $5,280,801 | +4.0% | 109,356 | +7.0% | 1.17% | +2.3% |
| Q4 2022 | $5,077,324 | +36.4% | 102,180 | +12.1% | 1.14% | +32.7% |
| Q3 2022 | $3,722,000 | -31.7% | 91,128 | -8.0% | 0.86% | -25.1% |
| Q2 2022 | $5,453,000 | +46.2% | 99,008 | -3.5% | 1.15% | +105.4% |
| Q1 2022 | $3,729,000 | +3.0% | 102,644 | +32.1% | 0.56% | +18.4% |
| Q4 2021 | $3,619,000 | – | 77,718 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 997,714 | $36,257,000 | 13.28% |
| JOHNSON & JOHNSON | 1,629,173 | $59,204,000 | 11.19% |
| Paradigm Biocapital Advisors LP | 831,728 | $30,225,000 | 7.99% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,100,542 | $39,994,000 | 5.54% |
| HHLR ADVISORS, LTD. | 6,936,617 | $252,077,000 | 5.26% |
| Old Well Partners, LLC | 79,700 | $2,896,000 | 1.94% |
| Parkman Healthcare Partners LLC | 120,473 | $4,378,000 | 1.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 4,500 | $5,632,000 | 1.27% |
| AtonRa Partners | 50,928 | $1,851,000 | 1.00% |
| Avidity Partners Management LP | 1,095,000 | $39,792,000 | 0.83% |